HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Free Full Text (PDF) Free All Versions of this Article: 100/2/637    most recent 00943.2005v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Wick, D. E. Articles by Charkoudian, N. Search for Related Content PubMed PubMed Citation Articles by Wick, D. E. Articles by Charkoudian, N.

Delayed threshold for active cutaneous vasodilation in patients with Type 2 diabetes mellitus

Departments of ¹Physiology and Biomedical Engineering, ²Anesthesiology, ³Neurology, and ⁴Endocrinology, Mayo Clinic College of Medicine, Rochester, Minnesota

Submitted 2 August 2005 ; accepted in final form 30 September 2005

Epidemiological evidence suggests decreased heat tolerance in patients with Type 2 diabetes mellitus (T2DM), but it is not known whether the mechanisms involved in thermoregulatory control of skin blood flow are altered in these patients. We tested the hypothesis that individuals with T2DM have a delayed internal temperature threshold for active cutaneous vasodilation during whole body heating compared with healthy control subjects. We measured skin blood flow using laser-Doppler flowmetry (LDF), internal temperature (T_or) via sublingual thermocouple, and mean arterial pressure via Finometer at baseline and during whole body heating in 9 T2DM patients and 10 control subjects of similar age, height, and weight. At one LDF site, sympathetic noradrenergic neurotransmission was blocked by local pretreatment with bretylium tosylate (BT) to isolate the cutaneous active vasodilator system. Whole body heating was conducted using a water-perfused suit. There were no differences in preheating T_or between groups (P > 0.10). Patients with T2DM exhibited an increased internal temperature threshold for the onset of vasodilation at both untreated and BT-treated sites. At BT-treated sites, T_or thresholds were 36.28 ± 0.07°C in controls and 36.55 ± 0.05°C in T2DM patients (P < 0.05), indicating delayed onset of active vasodilation in patients. Sensitivity of vasodilation was variable in both groups, with no consistent difference between groups (P > 0.05). We conclude that altered control of active cutaneous vasodilation may contribute to impaired thermoregulation in patients with T2DM.

temperature regulation; sweating; metabolic disorders

This article has been cited by other articles:

				L. A. Sokolnicki, N. A. Strom, S. K. Roberts, S. A. Kingsley-Berg, A. Basu, and N. Charkoudian Skin blood flow and nitric oxide during body heating in type 2 diabetes mellitus J Appl Physiol, February 1, 2009; 106(2): 566 - 570. [Abstract] [Full Text] [PDF]

				L. A. Sokolnicki, S. Khosla, and N. Charkoudian Effects of testosterone and estradiol on cutaneous vasodilation during local warming in older men Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1426 - E1429. [Abstract] [Full Text] [PDF]

				L. A. Holowatz and W. L. Kenney Up-regulation of arginase activity contributes to attenuated reflex cutaneous vasodilatation in hypertensive humans J. Physiol., June 1, 2007; 581(2): 863 - 872. [Abstract] [Full Text] [PDF]

				L. A. Sokolnicki, S. K. Roberts, B. W. Wilkins, A. Basu, and N. Charkoudian Contribution of nitric oxide to cutaneous microvascular dilation in individuals with type 2 diabetes mellitus Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E314 - E318. [Abstract] [Full Text] [PDF]